Literature DB >> 10674652

Protease production by Burkholderia pseudomallei and virulence in mice.

Y P Gauthier1, F M Thibault, J C Paucod, D R Vidal.   

Abstract

The aim of this study was to assess protease production and virulence of various Burkholderia pseudomallei strains. Protease activity was evaluated in filtrates from cultures grown for 50 h in TSB Dialysate by azocasein hydrolysis, and expressed as absorbancy at 405 nm. Virulence was assessed in 8 weeks old SWISS mice, by intraperitoneal injection of 6-6 x 10(5) CFU, and the LD50 was calculated after 30 days by the method of Reed and Muench. The lethal activity was studied for five strains of B. pseudomallei and the type strains of Burkholderia pseudomallei, Burkholderia mallei, and Burkholderia cepacia. The three type strains appeared to be low protease producers (A405 = 0.11, 0.09 and 0.00, respectively) and avirulent. The two more virulent B. pseudomallei strains exhibited significantly different LD50, 3.5 x 10(2) (IPP 6068 VIR) versus 2.1 x 10(5) CFU/mouse (40/97), and protease activities (A405 = 0.046 and 0.79, respectively). Moreover, the avirulent parent of IPP 6068 (AG), was a better protease producer than the 6068 VIR strain, A405 = 0.26 versus 0.046. These results suggest that there is no correlation between virulence and level of exoproteolytic activity, when B. pseudomallei is injected to mice via the intraperitoneal route.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674652     DOI: 10.1016/s0001-706x(99)00073-x

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  8 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  A Burkholderia pseudomallei macrophage infectivity potentiator-like protein has rapamycin-inhibitable peptidylprolyl isomerase activity and pleiotropic effects on virulence.

Authors:  Isobel H Norville; Nicholas J Harmer; Sarah V Harding; Gunter Fischer; Karen E Keith; Katherine A Brown; Mitali Sarkar-Tyson; Richard W Titball
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

3.  Disarming Burkholderia pseudomallei: structural and functional characterization of a disulfide oxidoreductase (DsbA) required for virulence in vivo.

Authors:  Philip M Ireland; Róisín M McMahon; Laura E Marshall; Maria Halili; Emily Furlong; Stephanie Tay; Jennifer L Martin; Mitali Sarkar-Tyson
Journal:  Antioxid Redox Signal       Date:  2013-09-20       Impact factor: 8.401

4.  The BpsIR quorum-sensing system of Burkholderia pseudomallei.

Authors:  Yan Song; Chao Xie; Yong-Mei Ong; Yunn-Hwen Gan; Kim-Lee Chua
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

5.  The PmlI-PmlR quorum-sensing system in Burkholderia pseudomallei plays a key role in virulence and modulates production of the MprA protease.

Authors:  E Valade; F M Thibault; Y P Gauthier; M Palencia; M Y Popoff; D R Vidal
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

6.  Analogous cytokine responses to Burkholderia pseudomallei strains contrasting in virulence correlate with partial cross-protection in immunized mice.

Authors:  Glen C Ulett; Natkunam Ketheesan; Timothy W Clair; Catriona L McElnea; Jodie L Barnes; Robert G Hirst
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

7.  Characterization of the mrgRS locus of the opportunistic pathogen Burkholderia pseudomallei: temperature regulates the expression of a two-component signal transduction system.

Authors:  Magdy E Mahfouz; T Hilton Grayson; David A B Dance; Martyn L Gilpin
Journal:  BMC Microbiol       Date:  2006-08-07       Impact factor: 3.605

8.  Characterization of Burkholderia pseudomallei protein BPSL1375 validates the Putative hemolytic activity of the COG3176 N-Acyltransferase family.

Authors:  Laziana Ahmad; Teng Loong Hung; Nor Azurah Mat Akhir; Rahmah Mohamed; Sheila Nathan; Mohd Firdaus-Raih
Journal:  BMC Microbiol       Date:  2015-11-23       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.